Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

CoreAge Rx vs RestorLife Med

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx
vs
Grade C · #66

RestorLife Med

RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr.

Visit RestorLife Med

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 77/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. RestorLife Med still earns its place — shoppers who want gLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

92Real-world results85
97Price honesty30
96Prescriber access92
88Formulary choice82
95Cancellation fairness92
93Member support92

Price, coverage & features

MetricCoreAge RxRestorLife Med
Verdict Score94/10077/100
GradeAC
Semaglutide$149/moFrom $199/mo (6-mo plan, compounded)
Tirzepatide$349/moNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualNoNo

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

RestorLife Med

What we like

  • Verifiable LegitScript certification (seal ID 50400451) plus a named board-certified physician (Dr. Michael Wasef, MD) licensed in all 50 states
  • Full GLP-1 lineup: compounded semaglutide and tirzepatide, plus gentler microdose entry options
  • Generous support — unlimited care-team messaging, monthly check-ins, dosage adjustments, and 1 free blood test per quarter on the GLP-1 protocols
  • Available in all 50 states with free priority shipping, discreet packaging, and roughly 48-hour delivery
  • Transparent multi-month pricing with 50% off your first month; semaglutide protocols are compounded with B12

The caveats

  • The advertised $299 is a struck-through anchor price, not a starting point: the real month-to-month rate is $299, a first month runs $149 at 50% off, and the $199 rate needs six months
  • The page states its pricing is 'introductory and subject to change', so none of these figures is committed to
  • The tirzepatide price is published the same way, against a struck-through anchor, and we could not establish which figure a buyer actually pays
  • A separate semaglutide microdose is sold at $99/mo — a sub-therapeutic protocol, not a cheaper weight-loss dose
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Also worth a look

Shoppers who want gLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support.

Visit RestorLife Med Read the full RestorLife Med review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programmes closest to it, and the same shortlist for RestorLife Med does the reverse.

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.